Patients of the placebo group

Degrees of hearingloss

RE (N˚ ptes)

Percentage RE

LE (N˚ ptes)

Percentage LE

Mild to moderate: 25 - 49 dBs

15

75.00%

6

30.00%

Moderate to severe: 50 - 59 dBs

5

25.00%

6

30.00%

Severe: 60 to 74 dBs

-

-

8

40.00%

Profound: >75 dBs

-

-

-

Patients of the deflazacort group

Mild to moderate: 25 - 49 dBs

10

45.00%

14

63.60%

Moderate to severe: 50 - 59 dBs

5

22.70%

3

13.60%

Severe: 60 to 74 dBs

5

22.70%

3

13.60%

Profound: >75 dBs

2

9.60

2

9.20%

Patients of the fludrocortisone group

Mild to moderate: 25 - 49 dBs

16

61.50%

18

69.20%

Moderate to severe: 50 - 59 dBs

3

11.60%

3

11.60%

Severe: 60 to 74 dBs

7

26.90%

4

15.30%

Profound: >75 dBs

-

-

1

3.90%

Patients of the nimodipine group

Mild to moderate: 25 - 49 dBs

12

54.50%

14

63.60%

Moderate to severe: 50 - 59 dBs

4

18.10%

2

9.30%

Severe: 60 to 74 dBs

4

18.10%

6

27.10%

Profound: >75 dBs

2

9.30%

-

-